Data from a Phase II clinical trial of patients with locally advanced or metastatic pancreatic cancer.
Usage
data("pancreatic")
Arguments
Format
A data frame with 41 observations on the following 4 variables.
stage
a factor with levels LA (locally advanced) or M (metastatic)
onstudy
date of enrollment into the clinical trial, in month/day/year format
progression
date of progression, in month/day/year format
death
date of death, in month/day/year format
Details
Since all patients in this study have known death dates, there is no censoring.
References
Moss RA, Moore D, Mulcahy MF, Nahum K, Saraiya B, Eddy S, Kleber M, and Poplin EA (2012)
A multi-institutional phase 2 study of imatinib mesylate and gemcitabine for first-line treatment of advanced pancreatic cancer. Gastrointestinal Cancer Research 5, 77 - 83.